Press releaseGlobe Newswire
Solid Biosciences
SLDB · NASDAQ
$6.40+$0.48 (+8.11%)TodayMarket closed ·
Prev close $5.92
Latest news
- NewsAvi Kapoor
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Press releaseGlobe Newswire
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
- News
Solid Biosciences Doses First Participant In Phase 3 IMPACT DUCHENNE Clinical Trial For SGT-003 In Duchenne Muscular Dystrophy
- Press releaseGlobe Newswire
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
- Press releaseGlobe Newswire
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
- Press releaseGlobe Newswire
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
- Press releaseGlobe Newswire
Solid Biosciences to Participate at Upcoming Investor Conferences
- Press releaseGlobe Newswire
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
- NewsVandana Singh
Solid Biosciences Touts Encouraging Results For Duchenne Gene Therapy, FDA Talks Planned
- Press releaseGlobe Newswire
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
- NewsVandana Singh
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- NewsAvi Kapoor
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- NewsAvi Kapoor
Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releasePRNewswire
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
- Press releaseGlobe Newswire
Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates
- Press releasePRNewswire
SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Solid Biosciences Inc. (NASDAQ: SLDB) and Encourages Long-Term SLDB Investors to Contact the Firm
- NewsVandana Singh
Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand
- Press releaseGlobe Newswire
Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
- News
Market-Moving News for February 18th
- Press releaseGlobe Newswire
Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines
- Press releaseGlobe Newswire
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.